World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ISRCTN
Last refreshed on: 13 January 2015
Main ID:  ISRCTN82161629
Date of registration: 19/12/2005
Prospective Registration: No
Primary sponsor: Pfizer B.V. (Netherlands) (Pfizer Inc, New York)
Public title: A study on the efficacy of the combination of growth hormone (GH) and gonadotropin releasing hormone analogues (GnRHa) on adult height in children with idiopathic short stature
Scientific title:
Date of first enrolment: 01/10/1993
Target sample size: 40
Recruitment status: Completed
URL:  http://isrctn.com/ISRCTN82161629
Study type:  Interventional
Study design:  Multicentre randomised open label active controlled parallel group trial (Treatment)  
Phase: 
Countries of recruitment
Netherlands
Contacts
Name: J.M.    Wit
Address:  Leiden University Medical Center Department of Pediatrics P.O. Box 9600 2300 RC Amsterdam Netherlands
Telephone: +31 (0)71 5262824
Email: j.m.wit@lumc.nl
Affiliation: 
Name:    
Address: 
Telephone:
Email:
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: 40 adolescents in early puberty, with a height <-2 Standard Deviation Score (SDS) or with a height SDS between -1 and -2, but a predicted adult height SDS <-2
Exclusion criteria: Disorders or medication influencing growth

Age minimum:
Age maximum:
Gender: Both
Health Condition(s) or Problem(s) studied
Small for Gestational Age (SGA), children with persistent short stature
Nutritional, Metabolic, Endocrine
Other endocrine disorders
Intervention(s)
Daily injections of Growth Hormone (GH) and monthly injections with GnRHa (Decapeptyl) for 3 years.
Regular controls at the clinic, blood investigations for effect and safety parameters, yearly X-rays of the hand, and yearly psychological assessment.
At final height, growth, psychological assessment, bone mineral density.
Primary Outcome(s)
Final height SDS minus initial height SDS
Secondary Outcome(s)
1. Final height SDS
2. Final height SDS minus initial height SDS
3. Final height SDS minus target height
4. Body mass index
5. Bone mineral density
6. Quality of life
Secondary ID(s)
N/A
Source(s) of Monetary Support
University Medical Centre Utrecht (UMCU) (Netherlands), Netherlands Organisation for Scientific Research (NWO) (Netherlands)
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history